AEZS-108 and Perifosine same old, what's the difference
If AEZS-108 was any better than Perifosine we wouldn't be sitting at a buck and change, I don't see any difference and the news releases look the same. I'm expecting more of the same old hype from the company right up to the announcement of failure of 108. After 3 years the conclusion is this company has nothing in cancer treatment except hype and stock dilutution
The companys product pipeline includes macimorelin acetate (AEZS-130) for which the company has filed a New Drug Application to the FDA as an oral product used for evaluating adult growth hormone deficiency; and the product is also in Phase II clinical trial for the treatment of cancer-induced cachexia.
Better DD, cover your shorts and don't try to scare us becouse we know what we are buying.